Acorda Therapeutics, Inc. (ACOR) - NASDAQ
  • timtrading | Send Message 21 Mar

    RSI oversold stocks $CLDX,$HRB,$POM,$MTW,$PTCT,$OREX,$ACOR,$LCI,$EBAYL http://bit.ly/1ErbFy2
    Reply
      • Brion Morrison | Send Message 3 Mar

        Biotie Acquisition Update $BITI, $ACOR http://seekingalpha.com/p/2w3wc
        Reply
          • Brion Morrison | Send Message 17 Feb

            35% Annualized Return From Acquisition Of Biotie $BITI, $ACOR http://seekingalpha.com/a/2bngo
            Reply
              • freefdawatchlist | Send Message 10 Feb

                http://bit.ly/1oteIjK Earning play for Feb 11th: $ACOR, $MWW, $WWE, $SA, $CYBR, $ZG, $KN, $P, $LPLA, $NUS
                Reply
                  • Life Sciences Report | Send Message 3 Feb

                    Look North For Value-Priced Growth In Healthcare: StoneCastle's Bruce Campbell $ACOR, $CPHR, $CVHIF http://seekingalpha.com/p/2u9ly
                    Reply
                      • Dan Stringer | Send Message 20 Jan

                        Stopped out of $ACOR; love what they are doing but need to keep the discipline on what is working.
                        Reply
                          • Bay Area Biotech | Send Message 5 Jan

                            Acorda Therapeutics: Developing Innovative Therapies For Neurological Diseases $ACOR http://seekingalpha.com/a/298ie
                            Reply
                              • ONeil Trader | Send Message 18 Dec 2015

                                Acorda Therapeutics: Cash Flow Positive With A Promising Pipeline $ACOR http://seekingalpha.com/a/28np8
                                Reply
                                  • StockConsultant | Send Message 15 Dec 2015

                                    $ACOR 4th breakout attempt, watch above 38.63 http://goo.gl/dLH3yt
                                    Reply
                                      • StockConsultant | Send Message 7 Dec 2015

                                        $ACOR nice bounce off 36.72 support, breakout watch above 38.72 http://goo.gl/NlBT9l
                                        Reply
                                          Company Description
                                          Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system. The company's two main products are Ampyra and... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States